Clinical Trial: Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417657) titled 'Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants' on Feb. 11.

Brief Summary: Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract infection in young children, and a substantial proportion of severe cases occur in previously healthy infants. The gut-lung axis suggests that gut microbiome composition may modulate respiratory immune responses. This prospective observational study in Vietnam will compare gut microbiome profiles and systemic immune cytokine responses between infants with severe RSV infection and those with mild RSV infection, aiming to identify microbiome-...